Atlas Trials

Non-Secretory Plasma Cell Myeloma

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Non-Secretory Plasma Cell Myeloma

RecordFirmDate
Panobinostat and Carfilzomib in Treating Participants With Relapsed or Refractory Multiple Myeloma (NCT01301807)M.D. Anderson Cancer Center2011-07-28

Track Non-Secretory Plasma Cell Myeloma automatically

Every clearance here is in the API, with alerts when new ones post.